We targeted editing of the Htra2 gene and demonstrated that knockout of the Htra2 gene by the adeno-associated virus (AAV)-mediated CRISPR/Cas9 system could effectively prevent aminoglycoside-induced ototoxic deafness in mice. Here, HTRA2 is linked to deafness.